Answers are grounded in this paper and cite their sources.
Bone defects caused by trauma, infection, or tumor resection remain difficult to repair, particularly when delayed union or nonunion is compounded by microbial colonization. Polymer nanofiber scaffolds offer a flexible platform for integrating structural support, local bioactivity, and immune modulation. Here, we report a surface-functionalized electrospun scaffold based on poly(L-lactic acid) (PLLA), silk fibroin (SF), and Al–Ti3C2Tx MXene, in which the antimicrobial peptide GL13K is immobilized through polydopamine (PDA) coating. The resulting scaffold retained a uniform nanofibrous morphology, increased hydrophilicity, improved tensile strength, and measurable electrical conductivity while showing low short-term degradation. In vitro, the scaffold exhibited broad-spectrum antibacterial activity against Escherichia coli and Staphylococcus aureus, supported MC3T3-E1 cell adhesion and proliferation, enhanced alkaline phosphatase activity and mineralized nodule formation, and upregulated osteogenic markers. Under lipopolysaccharide-stimulated macrophage culture, it reduced iNOS expression and increased CD206 expression, consistent with M2 polarization. In a rat calvarial defect model, the functionalized scaffold produced significantly higher bone volume fraction and trabecular thickness than control and component-only scaffolds at 4 and 8 weeks, with no obvious systemic toxicity in major organs. These results demonstrate that PDA-mediated GL13K functionalization of an electrospun PLLA/SF/MXene polymer scaffold provides an integrated antibacterial, immunomodulatory, and osteogenic design for bone defect repair.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: